Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators
Author(s) -
Jennifer L. Schneider,
James V. Davis,
Tia L. Kauffman,
Jacob A. Reiss,
Cheryl McGinley,
Kathleen Arnold,
Jamilyn M. Zepp,
Marian Gilmore,
Kristin R. Muessig,
Sapna Syngal,
Louise S. Acheson,
Georgia L. Wiesner,
Susan K. Peterson,
Katrina A.B. Goddard
Publication year - 2015
Publication title -
genetics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.509
H-Index - 128
eISSN - 1530-0366
pISSN - 1098-3600
DOI - 10.1038/gim.2015.43
Subject(s) - stakeholder , clarity , thematic analysis , staffing , nursing , health care , medicine , qualitative research , medical education , process management , knowledge management , business , public relations , computer science , social science , political science , biochemistry , chemistry , sociology , economics , economic growth
Evidence-based guidelines recommend that all newly diagnosed colon cancer be screened for Lynch syndrome (LS), but best practices for implementing universal tumor screening have not been extensively studied. We interviewed a range of stakeholders in an integrated health-care system to identify initial factors that might promote or hinder the successful implementation of a universal LS screening program.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom